US 9913822
Combination therapy with an anti-hyaluronan agent and therapeutic agent
granted A61KA61K31/337A61K31/37
Quick answer
US patent 9913822 (Combination therapy with an anti-hyaluronan agent and therapeutic agent) held by HALOZYME, INC. expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HALOZYME, INC.
- Grant date
- Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/337, A61K31/37, A61K31/42, A61K31/56